COSTS

USD 990/1,890 (includes course fee, lunch, book)

INFORMATION & REGISTRATION

For questions please contact:
Ralph Villiger

+ 41 76 321 90 86

ralph.villiger@avance.ch

AVANCE

LICENSE CONTRACT AND COMPANY VALUATION IN EXCEL

15 & 16 March, 2010, New York

18 & 19 March, 2010, Boulder

22 & 23 March, 2010, San Francisco

Deepen your valuation skills in one of our extensive two-day workshops in the USA. In this hands-on course you will learn how to use Excel for the valuation of a biotech firm, be it for fundraising, investing, or strategic decision taking. Solving a case study in Excel on your own laptop, you will be well prepared to take the learned skills back into practice.

COURSE OBJECTIVES

After the two days you should master:

  • rNPV valuation of projects, license contracts,
  • rNPV valuation of an entire biotech company,
  • Valuation of technology,
  • Choosing the proper discount rate for the valuation,
  • Monte Carlo simulation in Excel on a company level,
  • Taxes and valuation.

FACULTY

The course will be held by Ralph Villiger. He is a valuation specialist and advises Pharma, Biotech and investors around the globe. With Boris Bogdan he has authored numerous articles on valuation and has published the book "Valuation in Life Sciences: A Practical Guide." They are founders and partners of Avance, Basel GmbH and regulary teach on valuation.

PROGRAMME

Day 1:
• Principles of valuation
• Project valuation
• License contracts
• Case study in Excel: License contract
• Reading and structuring deals

Day 2:
• Discount rate
• Taxes & valuation
• Monte Carlo simulations
• Case study in Excel: Company valuation
• Strategic considerations

COSTS

1 day: USD 990 (includes course fee, lunch, teaching materials, book)

2 days: USD 1,890 (includes course fee, lunch, teaching materials, book)